Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...

In a report released today, Graham Doyle from UBS maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research ...

Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...

UBS analyst Graham Doyle maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) today and set a price target of ...

A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.